Clinical Trials Logo

Muscle Strain clinical trials

View clinical trials related to Muscle Strain.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05619887 Not yet recruiting - Dyspnea Clinical Trials

Muscle Reflex Inhibition in Hypoxic Exercise

Start date: June 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study is to compare muscle reflex function under settings of normoxia (normal oxygen level), acute hypoxia (brief oxygen-lack) and chronic hypoxia (long-duration exposure to oxygen-lack). The main question is: Does the muscle reflex adapt to chronic hypoxia? Young, healthy participants will complete light-to-high intensity cycling exercise with and without suppression of the muscle reflex. Suppression of the muscle reflex will be via spinal administration of the opioid Fentanyl. In the control condition, saline will be administered into the spinal space. Participants will complete control (saline) and experimental (Fentanyl) exercise conditions at sea-level (Kelowna, BC, Canada) breathing room air and whilst breathing a lower fraction of oxygen (acute hypoxia). Thereafter, participants will complete the exercise test after living at high altitude (White Mountain, CA, USA) for 2 weeks whilst breathing room air (chronic hypoxia) and breathing a higher fraction of oxygen (restored normoxia).

NCT ID: NCT05111652 Not yet recruiting - Electromyography Clinical Trials

Electromyographic Assessment of the Shoulder Stabilizing Musculature in CrossFit® Athletes

Start date: November 2021
Phase:
Study type: Observational

This is an observational analytical study of prevalent cases and controls.

NCT ID: NCT03322748 Not yet recruiting - Multiple Sclerosis Clinical Trials

Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple Sclerosis

Start date: February 2018
Phase: N/A
Study type: Interventional

The aim of the study (OVERACT_V1) is to verify if the isometric contraction of ankle plantarflexor and Hamstring muscles, induces a significant reduction of overactive bladder symptoms in patients with Multiple sclerosis.